Results 101 to 110 of about 13,321 (212)

Intestinal neutral ceramidase exacerbates MASH pathogenesis

open access: yeseGastroenterology
Background Metabolic dysfunction-associated steatotic liver disease and its more severe manifestation, metabolic dysfunction-associated steatohepatitis (MASH), are intimately linked to genetic factors, gut microbiota and barrier alteration.
Chao Lei   +10 more
doaj   +1 more source

A machine learning model for site-specific classification of N-glycoprotein fucosylation using tandem mass spectrometry and deep neural network

open access: yesJournal of Analytical Science and Technology
Protein fucosylation is a biologically significant post-translational modification that modulates protein stability, receptor signaling, and immune function.
Mina Park, Catia Mota, Heeyoun Hwang
doaj   +1 more source

Novel insight into FCSK‐congenital disorder of glycosylation through a CRISPR‐generated cell model

open access: yesMolecular Genetics & Genomic Medicine
Background FCSK‐congenital disorder of glycosylation (FCSK‐CDG) is a recently discovered rare autosomal recessive genetic disorder with defective fucosylation due to mutations in the fucokinase encoding gene, FCSK.
Maryam Fazelzadeh Haghighi   +5 more
doaj   +1 more source

Fucosyl glycosides for DC-SIGN targeting: Fucosylation strategies, synthesis and binding studies of model compounds

open access: yesBioorganic & Medicinal Chemistry
DC-SIGN, a C-type lectin receptor expressed on immune cells, is considered a promising target for immunomodulatory and antiviral therapies. While mannose-based glycomimetics have been extensively studied as DC-SIGN ligands, fucose-based strategies remain underexplored.
Chavan, Rohit   +5 more
openaire   +3 more sources

Comparison of knockdown approaches for the generation of stable cell populations expressing afucosylated antibodies. [PDF]

open access: yesMAbs
Tsachaki M   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy